ROCHE HOLDING AG

ROG
Delayed Swiss Exchange - 11:30:04 2023-02-03 am EST
282.35 CHF +3.10%
Business Summary
Healthcare
Pharmaceuticals & Medical Research
 Pharmaceuticals
  Pharmaceuticals
   Other Pharmaceuticals
Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.

Number of employees : 100 920 people.
Sales per Business
20202021
Pharmaceuticals46 491.0079.7%48 010.0076.4%
Diagnostics13 852.0023.8%17 840.0028.4%
CHF in Million
Sales per region
20202021
United States28 630.0049.1%28 065.0044.7%
Rest of Europe9 785.0016.8%11 381.0018.1%
Rest of Asia8 627.0014.8%9 762.0015.5%
Japan4 254.007.3%5 069.008.1%
Germany3 352.005.7%4 319.006.9%
Latin America2 393.004.1%2 746.004.4%
Switzerland1 101.001.9%2 117.003.4%
Africa, Australia and Oceania1 318.002.3%1 475.002.3%
Rest of North America883.001.5%916.001.5%
CHF in Million
Managers
Name Title
Severin Schwan Chief Executive Officer & Executive Director
Alan Hippe Chief Financial & Information Officer
Christoph Franz Chairman
Levi A. Garraway Chief Medical Officer
Pascale Schmidt Chief Compliance Officer
Andr S. Hoffmann Vice Chairman
Bernard J. Poussot Independent Non-Executive Director
Richard P. Lifton Independent Non-Executive Director
Claudia Sssmuth Dyckerhoff Independent Non-Executive Director
Anita Hauser Independent Non-Executive Director
Shareholders
Name Equities %
Roche Holding AG 62,159,409 8.85%
The Vanguard Group, Inc. 20,335,106 2.89%
Norges Bank Investment Management 18,011,252 2.56%
BlackRock Fund Advisors 12,334,247 1.76%
UBS Asset Management Switzerland AG 10,845,305 1.54%
Fidelity Management & Research Co. LLC 10,297,067 1.47%
Credit Suisse Asset Management (Schweiz) AG 9,129,432 1.30%
BlackRock Advisors (UK) Ltd. 6,239,237 0.89%
PRIMECAP Management Co. 5,560,379 0.79%
Massachusetts Financial Services Co. 5,490,902 0.78%
Company contact information
Roche Holding AG
Grenzacherstrasse 124
Basel, Basel-Stadt (Basle Town) 4058

Phone : +41.61.688.11.11
Fax : +41.61.691.93.91
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
ROCHE HOLDING AG-11.10%264 917
JOHNSON & JOHNSON-6.29%432 802
ELI LILLY AND COMPANY-6.36%314 224
NOVO NORDISK A/S-3.40%300 394
ROCHE HOLDING AG-5.73%264 917
MERCK & CO., INC.-6.75%262 312
ABBVIE INC.-10.38%256 060
PFIZER, INC.-14.19%248 894
ASTRAZENECA PLC-8.63%194 954
NOVARTIS AG-6.38%182 178
BRISTOL-MYERS SQUIBB COMPANY-1.00%161 524
AMGEN INC.-6.13%131 647
SANOFI-3.42%118 344
GILEAD SCIENCES, INC.-5.20%102 083
GSK PLC-0.71%70 685
BAYER AG17.54%61 012
DAIICHI SANKYO CO., LTD.-4.94%60 324
TAKEDA PHARMACEUTICAL COMPANY LIMITED-1.39%49 086
CHUGAI PHARMACEUTICAL CO., LTD-2.14%42 228
JIANGSU HENGRUI MEDICINE CO., LTD.11.08%40 759
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD5.60%27 745
Brand Portfolio
ROCHE
ROCHE
FLATIRON HEALTH
FLATIRON HEALTH
FOUNDATION MEDICINE
FOUNDATION MEDICINE
GENENTECH
GENENTECH
PROMEDIOR
PROMEDIOR
STRATOS GENOMICS
STRATOS GENOMICS
TROPHOS
TROPHOS
VIEWICS
VIEWICS
More brands of Roche Holding AG